VANCOUVER, June 22 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced the results of the Annual Shareholders Meeting held on June 21, 2009 in Hong Kong, China. There were 50,209,377 shares equaling 74.87% of the outstanding shares represented at this meeting. The shareholders re-elected the following eight persons to serve as members of the Board of Directors for the Company: Mr. Yanlin Han, Mr. Zhanguo Weng, Ms. Xuemei Liu, Dr. Alexander Wick, Ph.D., Dr. Yiu Kwong Sun, M.D., Mr. Peter Mak, Dr. Heinz Frey and Dr. Jin Li. DATASOURCE: Dragon Pharmaceutical Inc. CONTACT: Dragon Pharmaceutical Inc., Maggie Deng, COO, Telephone: (604) 669-8817, or North America Toll Free: 1-877-388-3784, Email: , Website: http://www.dragonpharma.com/

Copyright